Literature DB >> 15793807

Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides.

Cláudia R Gordijo1, César A S Barbosa, Ana M Da Costa Ferreira, Vera R L Constantino, Denise de Oliveira Silva.   

Abstract

The immobilization of the NSAID ibuprofen (Hibp) and the Cu(II)-ibp compound on magnesium-aluminum layered double hydroxides (Mg3Al-LDH) is described. Ibuprofen was intercalated on LDHs by three routes (ion exchange, co-precipitation, and reconstruction). The organic drug and the Cu(II)-ibp were also immobilized by adsorption on LDH external surfaces. Materials were characterized by elemental analysis, UV/VIS, FTIR, and Raman spectroscopies, powder X-ray diffractometry (XRD), thermogravimetry, and electronic paramagnetic resonance (EPR). Mg3Al-(ibp)(cop) (30% w/w of drug/material) and Mg3Al-(ibp)(ie) (33%) materials exhibit bilayer arrangements of ibp anions intercalated between the host layers. Mg3Al-(ibp)(rec) and Mg3Al-(ibp)(ads) contain 13% and 6.2% of ibuprofenate, respectively. Mg3Al-(Cu-ibp)(ads) exhibits two Cu centers in different environments interacting with host layers. Pharmacological potential of materials are compared considering the amounts of immobilized drugs and their buffering properties. Mg3Al-(ibp)(ie) and Mg3Al-(ibp)(cop) exhibit poor buffering property, but contain high ibp amounts. Mg3Al-(ibp)(ads) despite having buffering property, contains low amount of ibuprofen. Mg3Al-(ibp)(rec) combines significant amount of immobilized ibp with good buffering property. Mg3Al-(Cu-ibp)(ads), due to the buffering property, may be an interesting new formulation aiming to decrease gastric irritation. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793807     DOI: 10.1002/jps.20336

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics.

Authors:  Michelle Chakraborti; John K Jackson; David Plackett; Samuel E Gilchrist; Helen M Burt
Journal:  J Mater Sci Mater Med       Date:  2012-04-20       Impact factor: 3.896

2.  Anti-Inflammatory and Analgesic Evaluation of a Phytochemical Intercalated into Layered Double Hydroxide.

Authors:  Viviane A Guilherme; Vanessa R R Cunha; Eneida de Paula; Daniele R de Araujo; Vera R L Constantino
Journal:  Pharmaceutics       Date:  2022-04-25       Impact factor: 6.525

3.  The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins.

Authors:  Yan Hua Xue; Rui Zhang; Xiao Yu Sun; Shi Long Wang
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

4.  Interactions of ibuprofen with hybrid lipid bilayers probed by complementary surface-enhanced vibrational spectroscopies.

Authors:  Carly S Levin; Janardan Kundu; Benjamin G Janesko; Gustavo E Scuseria; Robert M Raphael; Naomi J Halas
Journal:  J Phys Chem B       Date:  2008-10-23       Impact factor: 2.991

5.  Synthesis and characterization of layered double hydroxides and their potential as nonviral gene delivery vehicles.

Authors:  Blake Balcomb; Moganavelli Singh; Sooboo Singh
Journal:  ChemistryOpen       Date:  2014-12-18       Impact factor: 2.911

6.  Synthesis and In Vitro Characterization of Fe3+-Doped Layered Double Hydroxide Nanorings as a Potential Imageable Drug Delivery System.

Authors:  Lijun Wang; Yusen Wang; Xiaoxia Wang
Journal:  Materials (Basel)       Date:  2017-09-27       Impact factor: 3.623

7.  Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies.

Authors:  Afzal Hussain; Mohamed Fahad AlAjmi; Md Tabish Rehman; Samira Amir; Fohad Mabood Husain; Ali Alsalme; Maqsood Ahmad Siddiqui; Abdulaziz A AlKhedhairy; Rais Ahmad Khan
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

8.  Layered double hydroxide-based nanocarriers for drug delivery.

Authors:  Xue Bi; Hui Zhang; Liguang Dou
Journal:  Pharmaceutics       Date:  2014-06-17       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.